Administration study as a part of research toward the development of detection method for erythropoietin preparations in biological samples
Not Applicable
- Conditions
- ot applicable
- Registration Number
- JPRN-jRCT1080221264
- Lead Sponsor
- Mitsubishi chemical Medience Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Weight: over 50 kg, BMI: under 18.5 and below 25
Exclusion Criteria
-Hypersensitivity to drugs,
-A history of alcoholism or drug addiction,
-Ethical or OTC pharmaceuticals administered within two weeks before
scheduled administration of the study drug,
-Supplement, grapefruit or its products, or foods containing Hypericum perforatum
consumed within one week before scheduled administration of the
study drug, and
- Not less than 200 mL of blood is collected within 30 days or not less than
400 mL of blood is collected within 90 days before scheduled administration
of the study drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method